101 related articles for article (PubMed ID: 7833274)
1. Generation of human natural killer cells from pharmacologically purged bone marrow.
Silva MR; Ascensao JL
Br J Haematol; 1995 Jan; 89(1):34-40. PubMed ID: 7833274
[TBL] [Abstract][Full Text] [Related]
2. Effect of pharmacological purging on natural killer cell number and activity in human bone marrow.
Cardoso AA; Fallon M; Mukherji B; Silva MR; Marusic M; Gaffney J; Ascensao JL
Clin Immunol Immunopathol; 1992 Aug; 64(2):106-11. PubMed ID: 1643743
[TBL] [Abstract][Full Text] [Related]
3. The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture.
Miller JS; Verfaillie C; McGlave P
Blood; 1992 Nov; 80(9):2182-7. PubMed ID: 1384796
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic origin of human natural killer (NK) cells: generation from immature progenitors.
Silva MR; Kessler S; Ascensao JL
Pathobiology; 1993; 61(5-6):247-55. PubMed ID: 7507682
[TBL] [Abstract][Full Text] [Related]
5. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
6. Enhanced lymphokine-activated killer cell activity by an immunomodulator, Roquinimex.
Vaz F; Silva MR; Ascensao JL
Br J Cancer; 1995 Dec; 72(6):1498-503. PubMed ID: 8519666
[TBL] [Abstract][Full Text] [Related]
7. In vitro effects of etoposide purging on natural killer cells.
Silva MR; Ascensao JL
J Hematother; 1995 Dec; 4(6):563-70. PubMed ID: 8846017
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of 4-hydroperoxycyclophosphamide and antimyeloid monoclonal antibodies on T and natural killer cells during bone marrow purging.
Zhong RK; Donnenberg AD; Rubin J; Ball ED
Blood; 1994 Apr; 83(8):2345-51. PubMed ID: 7512845
[TBL] [Abstract][Full Text] [Related]
9. Human natural killer cell development from bone marrow progenitors: analysis of phenotype, cytotoxicity and growth.
Lotzová E; Savary CA
Nat Immun; 1993; 12(4-5):209-17. PubMed ID: 8257827
[TBL] [Abstract][Full Text] [Related]
10. ASTA-Z 7557 impairs human natural killer (NK) cell activity.
Condiotti R; Slavin S; Nagler A
Leuk Res; 1996 Feb; 20(2):169-74. PubMed ID: 8628016
[TBL] [Abstract][Full Text] [Related]
11. Generation of human natural killer cells from immature progenitors does not require marrow stromal cells.
Silva MR; Hoffman R; Srour EF; Ascensao JL
Blood; 1994 Aug; 84(3):841-6. PubMed ID: 7519079
[TBL] [Abstract][Full Text] [Related]
12. Human natural killer cell development in a xenogeneic culture system.
Barão I; Vaz F; Almeida-Porada G; Srour EF; Zanjani ED; Ascensão JL
Br J Haematol; 2002 Sep; 118(3):885-92. PubMed ID: 12181062
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrow.
Almici C; Manoni L; Carlo-Stella C; Garau D; Cottafavi L; Rizzoli V
Bone Marrow Transplant; 1995 Jul; 16(1):95-101. PubMed ID: 7581136
[TBL] [Abstract][Full Text] [Related]
14. Role of interleukin 2 (IL 2) and hemopoietin-1 (H-1) in the generation of mouse natural killer (NK) cells from primitive bone marrow precursors.
Migliorati G; Cannarile L; Herberman RB; Bartocci A; Stanley ER; Riccardi C
J Immunol; 1987 Jun; 138(11):3618-25. PubMed ID: 2884255
[TBL] [Abstract][Full Text] [Related]
15. Enrichment of interleukin-2-responsive natural killer progenitors in human bone marrow.
Shibuya A; Kojima H; Shibuya K; Nagayoshi K; Nagasawa T; Nakauchi H
Blood; 1993 Apr; 81(7):1819-26. PubMed ID: 8461468
[TBL] [Abstract][Full Text] [Related]
16. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrow.
Mumcuoglu M; Naparstek E; Slavin S
Bone Marrow Transplant; 1990 Mar; 5(3):153-8. PubMed ID: 2184907
[TBL] [Abstract][Full Text] [Related]
17. Generation of natural killer cells from long-term cultures of mouse bone marrow.
Vecchini F; Delfino D; Patrene KD; DeLeo A; Lu L; Herberman RB; Boggs SS
Nat Immun; 1993; 12(1):1-16. PubMed ID: 8431659
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 augments the interleukin-2-dependent generation of natural killer cells from bone marrow precursors.
Migliorati G; Cannarile L; D'Adamio L; Herberman RB; Riccardi C
Nat Immun Cell Growth Regul; 1987; 6(6):306-15. PubMed ID: 3502358
[TBL] [Abstract][Full Text] [Related]
19. Natural killer (NK) cell activity in human long-term bone marrow cultures (LTBMC): effects of interleukin-2 (IL-2) and granulocyte-macrophage colony-stimulating factor (GM-CSF) on the progenitor cells.
Sitnicka E; Hansson M
Immunology; 1992 Jun; 76(2):292-8. PubMed ID: 1634251
[TBL] [Abstract][Full Text] [Related]
20. Variability in 4-hydroperoxycyclophosphamide activity during clinical purging for autologous bone marrow transplantation.
Jones RJ; Zuehlsdorf M; Rowley SD; Hilton J; Santos GW; Sensenbrenner LL; Colvin OM
Blood; 1987 Nov; 70(5):1490-4. PubMed ID: 3311205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
